0000000000744687

AUTHOR

Ian López-cruz

0000-0001-7252-8961

showing 3 related works from this author

Community-onset Pseudomonas aeruginosa urinary sepsis in elderly people: Predictive factors, adequacy of empirical therapy and outcomes.

2019

Purpose To know the predictive factors for Pseudomonas aeruginosa (PA) urinary sepsis in hospitalised elderly patients coming from community, the adequacy of empirical antibiotic therapy and its outcomes. Methods Retrospective case-control study conducted between 2007 and 2017. Patients aged 65 years or older with PA urinary sepsis were included as cases. Three age-matched controls, with urinary sepsis caused by other microorganisms, were selected for each case. Predictors for PA urinary sepsis were determined by logistic regression analysis. Adequacy of empirical antibiotic therapy and outcomes were compared between both groups. Results A total of 332 patients, from which 83 were cases, we…

medicine.medical_specialtybusiness.industryPseudomonas aeruginosaUrinary systemGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasemedicine.disease_causeLogistic regressionEmpirical antibiotic therapySepsis03 medical and health sciences0302 clinical medicineInternal medicinemedicineElderly people030212 general & internal medicinebusinessUrinary catheterCommunity onsetInternational journal of clinical practiceREFERENCES
researchProduct

Prognostic accuracy of Quick SOFA in older adults hospitalised with community acquired urinary tract infection

2021

Introduction Quick [Sepsis-related] Sequential Organ Failure Assessment (qSOFA) is a prognostic score based on sepsis-3 definition, easy to carry out, whose application has been studied in older adults with sepsis from different sources and respiratory sepsis. However, to date no study has analysed its prognostic accuracy in older adults admitted to hospital with community urinary tract infection. Methods In a prospective study of 282 older adults admitted to hospital with community acquired urinary tract infection, the application of qSOFA to predict hospital mortality was analysed. The predictive capacity of qSOFA for in-hospital mortality was compared with Systemic Inflammatory Response …

Malemedicine.medical_specialtyOrgan Dysfunction ScoresUrinary systemPopulationPrognostic scoreSepsisSepsisInternal medicinemedicineHumansHospital MortalityProspective StudieseducationProspective cohort studyAgedRetrospective StudiesAged 80 and overeducation.field_of_studyReceiver operating characteristicbusiness.industrySeptic shockGeneral MedicinePrognosismedicine.diseaseSystemic Inflammatory Response SyndromeSystemic inflammatory response syndromeIntensive Care UnitsROC CurveUrinary Tract InfectionsbusinessInternational Journal of Clinical Practice
researchProduct

Fungal Necrotizing Scleritis After Intravitreal Injection Therapy

2020

PURPOSE To report a case of infectious necrotizing scleritis secondary to Aspergillus terreus after intravitreal injection therapy. METHODS This is a case report with literature review. RESULTS A 98-year-old woman receiving intravitreal aflibercept injections for neovascular age-related macular degeneration in the left eye presented with severe pain, redness, and purulent discharge at the injection site. She was initially treated with topical fortified antibiotics, and clinical improvement was achieved, although microbial cultures showed negative results. Two months later, she presented with severe ocular pain and was diagnosed with anterior necrotizing scleritis. Scleral scrapings were col…

medicine.medical_specialtyAntifungal Agentsmedicine.drug_classRecombinant Fusion ProteinsAntibioticsAngiogenesis InhibitorsmedicineAspergillosisHumansAspergillus terreusNecrotizing scleritisAfliberceptAged 80 and overVoriconazolebiologybusiness.industryInjection therapyMacular degenerationmedicine.diseasebiology.organism_classificationSurgeryOphthalmologyAspergillusReceptors Vascular Endothelial Growth FactorAcute DiseaseIntravitreal InjectionsWet Macular DegenerationEtiologyFemalebusinessEye Infections FungalScleraScleritismedicine.drugCornea
researchProduct